Advances in the discovery and development of trematocidal drugs
- 5 October 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 2 (sup1) , S9-S23
- https://doi.org/10.1517/17460441.2.s1.s9
Abstract
(2007). Advances in the discovery and development of trematocidal drugs. Expert Opinion on Drug Discovery: Vol. 2, No. sup1, pp. S9-S23. doi: 10.1517/17460441.2.S1.S9Keywords
This publication has 110 references indexed in Scilit:
- In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome SpeciesAntimicrobial Agents and Chemotherapy, 2007
- Evaluation of the In Vivo Activity of Tribendimidine against Schistosoma mansoni , Fasciola hepatica , Clonorchis sinensis , and Opisthorchis viverriniAntimicrobial Agents and Chemotherapy, 2007
- Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease InhibitorPLoS Medicine, 2007
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- A blueprint for success: integration of neglected tropical disease control programmesTrends in Parasitology, 2006
- Control of Neglected Tropical Diseases: Integrated Chemotherapy and BeyondPLoS Medicine, 2006
- Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and MalariaPLoS Medicine, 2006
- A New Era of Hope for the World's Most Neglected DiseasesPLoS Medicine, 2005
- A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We NeedPLoS Medicine, 2005
- Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical TrialsAntimicrobial Agents and Chemotherapy, 2003